Use: Labeled indications
- Uses temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander
Full indications and usage US FDA label
Uses temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander
Dosing: Adult
Dosage and administration (US label) US FDA label
Directions Adults and children 6 years of age and older: Instill 1 or 2 drops in the affected eye(s) up to 4 times daily. Children under 6 years: ask a doctor
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per ml sterile ophthalmic solution: 2.2 mg/100 mcg, 3 mg/250 mcg
- Ml ophthalmic solution: 3 mg/250 mcg
- Per ml: 3 mg/250 mcg
Registered products in the Philippines
7 products registered with the Food and Drug Administration (FDA) Philippines list Naphazoline + Pheniramine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products7
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AllerloupePheniramine Maleate + Naphazoline Hydrochloride | 3 mg/ 250 mcg per mL Sterile Ophthalmic SolutionPlastic Squeeze White Bottle x 10 mL (Box of 1's) | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | PNJ Pharma EnterpriseTrader: Medilife Pharma, Inc. | DRP-623-04 | Oct 9, 2027 | |
Decocon APheniramine Maleate + Naphazoline Hydrochloride | 3 mg/250 mcg per mL Sterile Ophthalmic Solution (Eye Drops)10 mL LDPE dropper container (Box of 1's) | Rx | ASHFORD PHARMACEUTICAL LABORATORIES, INC.Philippines | Trader: SENSOMED PHILS., INC. | DR-XY16681 | Feb 13, 2029 | |
IrazolPheniramine Maleate + Naphazoline Hydrochloride | 3 mg/250 mcg per mL Sterile Ophthalmic SolutionPlastic Squeeze White Bottle x 10 mL (Box of 1's) | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Medilife Pharma, Inc. | DRP-623 | Oct 9, 2027 | |
Naphcon-APheniramine Maleate/ Naphazoline Hydrochloride | 3 mg/ 250 mcg/ mL Ophthalmic SolutionPlastic Droptainer Dispenser x 15 mL (Box of 1's) | Rx | Alcon Singapore Manufacturing Pte. Ltd.Singapore | Importer: Alcon Laboratories (Phils.), Inc. | DR-XY4858 | Sep 1, 2027 | |
NonePheniramine (as Maleate) + Naphazoline Hydrochloride | 2.2 mg/100 mcg per mL (0.22% w/v / 0.01% w/v) Sterile Ophthalmic Solution10 mL White LDPE Bottle, dropper plug, and tamper evident cap in a box | Rx | EL Laboratories, Inc.Philippines | Trader: Celsus Pharmaceuticals Phils., Inc. | DR-XY40553 | Jan 19, 2027 | |
PhenazolPheniramine Maleate + Naphazoline Hydrochloride | Ophthalmic Solution and 3 mg/250 mcg per mLLDPE Plastic Dropper-Tipped Bottle x 10 mL (Box of 1's); LDPE Plastic Dropper-Tipped Bottle x 2.5 mL (Physician Sample) (Box of 1's) | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Vendiz Pharmaceuticals Inc. | DRP-12782 | Nov 12, 2029 | |
VistallergPheniramine Maleate + Naphazoline Hydrochloride | 3 mg/250 mcg per mL (0.3% w/v/0.025% w/v) Sterile Ophthalmic Solution (Drops)10 mL HDPE pilfer-guard eyedropper plastic container in a box | Rx | EL Laboratories, Inc.Philippines | Trader: Vista Pharma, Inc. | DR-XY27526 | Apr 20, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
Warnings For external use only Do not use if you are sensitive to any ingredient in this product if solution changes color or becomes cloudy Ask a doctor before use if you have heart disease high blood pressure trouble urinating due to an enlarged prostate gland narrow angle glaucoma When using this product overuse may cause more eye redness pupils may become enlarged temporarily do not touch tip of container to any surface to avoid contamination you may feel a brief tingling after putting drops in eye replace cap after use remove contact lenses before using Stop use and ask a doctor if you experience eye pain changes in vision redness or irritation of the eye that worsens or lasts more than 72 hours Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Accidental oral ingestion in infants and children may lead to coma and marked reduction in body temperature.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Opcon-A · Bausch & Lomb Incorporated [US FDA-approved label, version 2, March 20, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d7cfae7-8af4-4fee-93e1-e5cfe455c5a5
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .